We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Gene Mutation Identified That Can Trigger Lymphoblastic Leukemia

By LabMedica International staff writers
Posted on 05 Jul 2015
Print article
Image: Blood smear of child with acute lymphoblastic leukemia (Photo courtesy of Ohio State University).
Image: Blood smear of child with acute lymphoblastic leukemia (Photo courtesy of Ohio State University).
Image: Dual-Luciferase Reporter Assay kit (Photo courtesy of Promega).
Image: Dual-Luciferase Reporter Assay kit (Photo courtesy of Promega).
Some familial platelet disorders are associated with predisposition to leukemia, myelodysplastic syndrome (MDS) or dyserythropoietic anemia.

A family with autosomal dominant thrombocytopenia, high erythrocyte mean corpuscular volume (MCV) and two occurrences of B cell–precursor acute lymphoblastic leukemia (ALL) have been identified.

An international team of scientists led by those at Wayne State University (Detroit, MI, USA) screened 23 families with similar phenotypes using whole-exome sequencing to identify a heterozygous single-nucleotide change in the oncogene Ets Variant 6 (ETV6).

ETV6 was initially identified as a tumor suppressor by its involvement in somatic translocations in childhood leukemia. The team found three families with germline mutations in ETV6 and defects in hematopoiesis.

The investigators used a battery of methods to identify variants in the gene. These included exome sequencing carried out on the HiSeq 2000 system (Illumina; San Diego, CA, USA); platelet and bone marrow ribonucleic acid (RNA) sequencing; luciferase reporter assays which were analyzed using the Dual-Luciferase Reporter Assay kit (Promega; Madison, WI, USA). The team also used high-resolution laser immunofluorescence confocal microscopy using a Quorum spinning-disc confocal inverted epifluorescence microscope (Olympus, Shinjuku, Tokyo, Japan).

Of the 23 families with similar phenotypes the team identified two with ETV6 mutations. One family also had a mutation encoding p.Pro214Leu and one individual with ALL. The other family had a c.1252A>G transition producing a p.Arg418Gly substitution in the DNA-binding domain, with alternative splicing and exon skipping. Functional characterization of these mutations showed aberrant cellular localization of mutant and endogenous ETV6, decreased transcriptional repression and altered megakaryocyte maturation. The findings underscore a key role for ETV6 in platelet formation and leukemia predisposition.

Michael Callaghan, MD, an assistant professor of Pediatrics and coauthor of the study said, “Our findings underscore a key role for ETV6 in platelet formation and leukemia predisposition and the mutation occurs through ‘aberrant cellular localization’ of the gene, which can result in ‘decreased transcriptional repression’ during white blood cell formation. What we think that means is that ETV6's job is to 'turn off' growth, but when you have this mutation, it can't turn it off because it's in the wrong place. It's usually supposed to sit on the DNA and keep things (including cancer) from getting made, but when you have this mutation, instead of sitting on the DNA it's sitting in a different part of the cell and that predisposes you to getting a (blood) cancer.” The study was published in the May 2015 issue of the journal Nature Genetics.

Related Links:

Wayne State University 
Illumina 
Promega 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.